NCT06053528 is a clinical trial of Antibiotic in Chest--Diseases, sponsored by Assiut University.

Who is sponsoring NCT06053528?

NCT06053528 is sponsored by Assiut University.

What drugs are being tested in NCT06053528?

Interventions in NCT06053528: Antibiotic.

What condition does NCT06053528 study?

NCT06053528 studies Chest--Diseases.

Is NCT06053528 still recruiting?

NCT06053528 is currently status unknown. Last updated 25 September 2023.

Last reviewed 2023-09-25 · How we verify

NCT06053528

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pattern and Outcomes of Chest Diseases

Status unknown Last updated 25 September 2023

What this trial tests

trial testing Antibiotic in Chest--Diseases in 2,000 participants. Status unknown.

Timeline

1 October 2023

Primary endpoint
1 October 2024

1 December 2024

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	2,000
Start date	1 October 2023
Primary completion	1 October 2024
Estimated completion	1 December 2024

Drugs / interventions tested

Antibiotic — full drug profile →

Conditions studied

Chest--Diseases — all drugs for Chest--Diseases →

Sponsor

Assiut University

Who can join

Adults 18 to 90, any sex, with Chest--Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to determine the pattern and outcome of respiratory diseases in adults patients admitted to the Department of Chest Diseases at Assiut University Hospital.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Antibiotic

Trials testing the same drug.

NCT07454772 — Antibiotics vs Corticosteroids in Treatment of Granulomatous Lobular Mastitis · Phase 1, PHASE2 · not yet recruiting
NCT07492329 — Antibiotics vs Surgery in Acute Appendicitis · NA · active not recruiting
NCT06517264 — Effectiveness and Safety of Outpatient Treatment of Uncomplicated Acute Diverticulitis Without Antibiotics · NA · enrolling by invitation
NCT06640439 — LED Therapy for Third Molar Surgery · EARLY_PHASE1 · not yet recruiting
NCT06628076 — Antibacterial Effect of Zinc Oxide Nanoparticles on Acinetobacter Baumannii Isolated from Patients with Hospital Acquire · not yet recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06053528 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 25 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06053528.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing